A detailed history of Nisa Investment Advisors, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 73 shares of BMEA stock, worth $458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73
Previous 33 121.21%
Holding current value
$458
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$4.23 - $10.1 $169 - $404
40 Added 121.21%
73 $0
Q2 2024

Jul 19, 2024

BUY
$4.14 - $15.3 $74 - $275
18 Added 120.0%
33 $0
Q1 2024

May 01, 2024

BUY
$13.92 - $19.5 $208 - $292
15 New
15 $0
Q3 2023

Nov 02, 2023

SELL
$13.44 - $23.02 $94 - $161
-7 Reduced 53.85%
6 $0
Q2 2023

Aug 11, 2023

BUY
$21.66 - $41.8 $281 - $543
13 New
13 $0

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $184M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.